OTC: HNOI
HNO International, Inc.CIK 0001342916 · SIC 1000 · Metal Mining
Micro
Revenue $66K
Assets $1M
as of Oct 11, 2026
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (MU 10-K) is open in full — no account needed.
10-Q
Filed Sep 21, 2026
· Period ending Jul 31, 2026
Summary not yet generated.
8-K
Filed Sep 11, 2026
· Period ending Sep 4, 2026
Summary not yet generated.
Partner
Trade HNOI commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
424B3
Filed Jul 28, 2026
Summary not yet generated.
S-1
Filed Jul 21, 2026
Summary not yet generated.
10-Q
Filed Jul 7, 2026
· Period ending Apr 30, 2026
Summary not yet generated.
8-K
Filed May 8, 2026
· Period ending May 5, 2026
Summary not yet generated.
8-K
Filed May 1, 2026
· Period ending Apr 27, 2026
Summary not yet generated.
8-K
Filed Apr 17, 2026
· Period ending Apr 7, 2026
Summary not yet generated.
8-K
Filed Apr 16, 2026
· Period ending Apr 13, 2026
Summary not yet generated.
Latest financial statements
From 10-Q filed Sep 21, 2026 (period ending Jul 31, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Statements of Operations (Unaudited)
| Description | Three months ended July 31, 2026 | Three months ended July 31, 2025 | Nine months ended July 31, 2026 | Nine months ended July 31, 2025 |
|---|---|---|---|---|
| Revenue | — | — | 33,821 | 43,708 |
| Cost of goods sold | — | — | — | — |
| Gross Profit | — | — | 33,821 | 43,708 |
| Operating expenses | ||||
| Advertising and marketing | — | 2,610 | 2,559 | 22,770 |
| General and administrative expenses | 186,014 | 180,560 | 472,583 | 796,989 |
| Share commitment expenses | — | 241,380 | 55,000 | 5,333,937 |
| Depreciation | 63,716 | 66,742 | 192,369 | 178,730 |
| Total Operating Expenses | 249,730 | 491,292 | 722,511 | 6,332,426 |
| Net loss from Operations | (249,730) | (491,292) | (688,690) | (6,288,718) |
| Other Income (Expenses) | ||||
| Interest income | 11 | 2 | 17 | 8 |
| Interest expense | (94,086) | (6,705) | (140,651) | (20,569) |
| Gain/(Loss) on fair value of convertible note | (143,229) | (15) | (231,390) | (15,000) |
| Gain/(Loss) on derivative | (45,175) | — | (98,878) | — |
| Loss on write-off of intangible asset | — | — | — | (105,190) |
| Total Other (Expenses) | (282,479) | (6,718) | (470,902) | (140,751) |
| Net Loss | (532,209) | (498,010) | (1,159,592) | (6,429,469) |
| PER SHARE AMOUNTS | ||||
| Basic and diluted net loss per share | (0.01) | (0.01) | (0.01) | (0.04) |
| Weighted average number of common shares outstanding basic and diluted | 102,198,076 | 85,983,969 | 101,792,638 | 171,019,802 |
| The accompanying notes are an integral part of these condensed unaudited financial statements. | ||||
Condensed Balance Sheets
| Description | July 31, 2026 Unaudited | October 31, 2025 Audited |
|---|---|---|
| Current Assets | ||
| Cash | 69,427 | 9,525 |
| Accounts receivable | — | 332,669 |
| Other receivable | 18 | 1,018 |
| Total Current Assets | 69,445 | 343,212 |
| Non-Current Assets | ||
| Property and equipment, net | 1,143,987 | 1,323,189 |
| Right-of-use asset | 20,197 | 64,637 |
| Total Non-Current Assets | 1,164,184 | 1,387,826 |
| TOTAL ASSETS | 1,233,629 | 1,731,038 |
| LIABILITIES AND STOCKHOLDERS' DEFICIT | ||
| LIABILITIES | ||
| Current Liabilities | ||
| Accounts payable | 395,056 | 715,236 |
| Accrued interest payable | 76,913 | 56,345 |
| Lease liability | 20,702 | 60,953 |
| Advances, related party | 1,273,430 | 1,088,385 |
| Convertible notes payable, net of discounts and issue costs | 99,685 | 59,867 |
| Notes payable, related party | 785,000 | 785,000 |
| Derivative liability | 450,164 | — |
| Total Current Liabilities | 3,100,950 | 2,765,786 |
| Non-Current Liability | ||
| Lease liability | — | 5,202 |
| Long term notes payable, related party | 590,000 | 590,000 |
| Total Non-Current Liability | 590,000 | 595,202 |
| Total Liabilities | 3,690,950 | 3,360,988 |
| STOCKHOLDERS’ DEFICIT | ||
| Preferred stock, par value $0.001 per share; 15,000,000 shares authorized | ||
| Series A, par value $0.001 per share; 10,000,000 shares authorized; 5,000,000 and 5,000,000 shares issued and outstanding as of July 31, 2026 and October 31, 2025, respectively | 5,000 | 5,000 |
| Series B, par value $0.001 per share; 500,000 shares authorized; 360,000 and 360,000 shares issued and outstanding as of July 31, 2026 and October 31, 2025, respectively | 360 | 360 |
| Common stock, par value $0.001 per share; 985,000,000 shares authorized; 102,355,323 and 100,795,491 shares issued and outstanding as of July 31, 2026 and October 31, 2025, respectively | 102,356 | 100,795 |
| Common stock payable | 25,250 | 25,250 |
| Common stock subscription receivable | (13,750) | (13,750) |
| Additional paid-in capital | 50,633,245 | 50,302,585 |
| Accumulated deficit | (53,209,782) | (52,050,190) |
| Total Stockholders’ Deficit | (2,457,321) | (1,629,950) |
| TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT | 1,233,629 | 1,731,038 |
| The accompanying notes are an integral part of these condensed unaudited financial statements. | ||
Condensed Statements of Cash Flows (Unaudited)
| Description | Nine months ended July 31, 2026 | Nine months ended July 31, 2025 |
|---|---|---|
| Cash Flow from Operating Activities | ||
| Net loss | (1,159,592) | (6,429,469) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation | 192,369 | 178,730 |
| Non cash interest expenses | 111,685 | — |
| Legal services provided in exchange for convertible note | — | 45,000 |
| Loss on write-off of intangible asset | — | 105,190 |
| (Gain)/Loss on fair value of convertible note | 231,390 | 15,000 |
| (Gain)/Loss on derivative liability | 98,878 | — |
| Share based compensation | — | 5,333,937 |
| Commitment shares issued for financing expense | 55,000 | — |
| Changes in operating assets and liabilities: | ||
| (Increase)/Decrease in accounts receivable | 332,669 | — |
| (Increase)/Decrease in other receivable | 1,000 | — |
| (Decrease) in accounts payable | (320,180) | (129,137) |
| Increase/(Decrease) in accrued payroll | — | (17,762) |
| Increase in accrued interest payable | 20,568 | 20,569 |
| Operating lease ROU assets and lease liabilities, net | (1,013) | 115 |
| Net Cash Used in Operating Activities | (437,226) | (877,827) |
| Cash Flows from Financing Activities | ||
| Proceeds from related party advances | 230,045 | 509,000 |
| Repayment of related party advances | (45,000) | (378,000) |
| Proceeds from sale of common stock | 67,500 | 936,500 |
| Proceeds from issuance of convertible notes payable | 407,750 | — |
| Repayment of convertible notes payable | (150,000) | — |
| Net Cash Provided by Financing Activities | 510,295 | 1,067,500 |
| Cash Flows from Investing Activities | ||
| Purchase of property and equipment | (13,167) | (177,944) |
| Net Cash Used in Investing Activities | (13,167) | (177,944) |
| Net increase (decrease) in cash | 59,902 | 11,729 |
| Cash at beginning of period | 9,525 | 20,255 |
| Cash at end of period | 69,427 | 31,984 |
| Supplemental Disclosure for Cash Paid: | ||
| Lease liability paid during the period | 46,695 | — |
| Income taxes paid during the period | — | — |
| Interest paid during the period | 897 | — |
| Supplemental Disclosure for Non-Cash Investing and Financing Activities: | ||
| Property and equipment acquired through accounts payable | — | 398,845 |
| Common stock issued in settlement of common stock payable | 60,000 | — |
| Common stock cancellation per share exchange agreement | — | (360,000) |
| Series B preferred stock issuance per exchange agreement | — | 360,000 |
| Shares issued upon conversion of convertible notes payable | 47,446 | — |
| Convertible note issued in exchange for legal services, recorded at fair value | — | 60,000 |
| Derivative liability balance | 450,164 | — |
Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗